연구동향 분석

Multicenter Study of Antimicrobial Susceptibility of Anaerobic Bacteria in Korea in 2012

이양순 어영 이경원 박연준 김미나 김명숙 2015년

논문상세정보
인용/피인용
' Multicenter Study of Antimicrobial Susceptibility of Anaerobic Bacteria in Korea in 2012' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • anaerobe
  • imipenem
  • moxifloxacin
  • multicenter
  • tigecycline
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,606 0

0.0%

' Multicenter Study of Antimicrobial Susceptibility of Anaerobic Bacteria in Korea in 2012' 의 참고문헌

  • Wadsworth-KTL anaerobic bacteriology manual
    Jousimies-Somer HR 55-70 [2002]
  • Wadsworth-KTL Anaerobic bacteriology manual
    Jousimies-Somer HR Star Publishing Co : 55 ~ 70 [2002]
  • Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria
    Wybo I J Antimicrob Chemother 59 : 132 ~ 139 [2007]
  • Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria
    Wybo I J Antimicrob Chemother 59 132-139 [2007]
  • The US Food and Drug Administration. FDA Approved Drug Products Label for Tygacil, NDA no. 021821
  • Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic isolates to co-amoxiclav and five other antimicrobial agents
    Koeth LM J Antimicrob Chemother 53 : 1039 ~ 1044 [2004]
  • Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic isolates to co-amoxiclav and five other antimicrobial agents
    Koeth LM J Antimicrob Chemother 53 1039-1044 [2004]
  • Reemergence of anaerobic bacteremia
    Lassmann B Clin Infect Dis 44 : 895 ~ 900 [2007]
  • Reemergence of anaerobic bacteremia
    Lassmann B Clin Infect Dis 44 895-900 [2007]
  • Prevalence of antimicrobial resistance among clinical isolates of Bacteroides fragilis group in Canada in 2010-2011: CANWARD surveillance study
    Karlowsky JA Antimicrob Agents Chemother 56 : 1247 ~ 1252 [2012]
  • Prevalence of antimicrobial resistance among clinical isolates of Bacteroides fragilis group in Canada in 2010-2011: CANWARD surveillance study
    Karlowsky JA Antimicrob Agents Chemother 56 1247-1252 [2012]
  • New cfiA variant and novel insertion sequence elements in carbapenem-resistant Bacteroides fragilis isolates from Korea
    Roh KH Diagn Microbiol Infect Dis 66 : 343 ~ 348 [2010]
  • New cfiA variant and novel insertion sequence elements in carbapenem-resistant Bacteroides fragilis isolates from Korea
    Roh KH Diagn Microbiol Infect Dis 66 343-348 [2010]
  • National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004
    Snydman DR Antimicrob Agents Chemother 51 : 1649 ~ 1655 [2007]
  • National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004
    Snydman DR Antimicrob Agents Chemother 51 1649-1655 [2007]
  • Moxifloxacin resistance is prevalent among Bacteroides and Prevotella species in Greece
    Papaparaskevas J J Antimicrob Chemother 62 : 137 ~ 141 [2008]
  • Moxifloxacin resistance is prevalent among Bacteroides and Prevotella species in Greece
    Papaparaskevas J J Antimicrob Chemother 62 137-141 [2008]
  • Methods for antimicrobial susceptibility testing of anaerobic bacteria; Approved standard, 8th ed. M11-A8
    Clinical and Laboratory Standards Institute Clinical and Laboratory Standards Institute [2012]
  • Manual of clinical microbiology
    Citron DM ASM Press : 1204 ~ 1214 [2011]
  • Manual of clinical microbiology
    Citron DM 1204-1214 [2011]
  • Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007)
    Snydman DR Clin Infect Dis 50 (S1) : S26 ~ 33 [2010]
  • Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007)
    Snydman DR Clin Infect Dis 50 S1 S26-33 [2010]
  • In vitro activities of tigecycline against the Bacteroides fragilis group
    Jacobus NV Antimicrob Agents Chemother 48 : 1034 ~ 1036 [2004]
  • In vitro activities of tigecycline against the Bacteroides fragilis group
    Jacobus NV Antimicrob Agents Chemother 48 1034-1036 [2004]
  • In vitro activities of tigecycline against recently isolated Gram-negative anaerobic bacteria in Greece, including metronidazole-resistant strains
    Katsandri A Diagn Microbiol Infect Dis 55 : 231 ~ 236 [2006]
  • In vitro activities of tigecycline against recently isolated Gram-negative anaerobic bacteria in Greece, including metronidazole-resistant strains
    Katsandri A Diagn Microbiol Infect Dis 55 231-236 [2006]
  • Examination of cfiA-mediated carbapenem resistance in Bacteroides fragilis strains from a European antibiotic susceptibility survey
    Sóki J Int J Antimicrob Agents 28 : 497 ~ 502 [2006]
  • Examination of cfiA-mediated carbapenem resistance in Bacteroides fragilis strains from a European antibiotic susceptibility survey
    Sóki J Int J Antimicrob Agents 28 497-502 [2006]
  • Clinical significance of overexpression of multiple RND-family efflux pumps in Bacteroides fragilis isolates
    Pumbwe L J Antimicrob Chemother 58 : 543 ~ 548 [2006]
  • Clinical significance of overexpression of multiple RND-family efflux pumps in Bacteroides fragilis isolates
    Pumbwe L J Antimicrob Chemother 58 543-548 [2006]
  • Clinical efficacy and correlation of clinical outcomes with in vitro susceptibility for anaerobic bacteria in patients with complicated intra-abdominal infections treated with moxifloxacin
    Goldstein EJ Clin Infect Dis 53 : 1074 ~ 1080 [2011]
  • Clinical efficacy and correlation of clinical outcomes with in vitro susceptibility for anaerobic bacteria in patients with complicated intra-abdominal infections treated with moxifloxacin
    Goldstein EJ Clin Infect Dis 53 1074-1080 [2011]
  • Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents
    Citron DM J Clin Microbiol 45 : 2819 ~ 2828 [2007]
  • Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents
    Citron DM J Clin Microbiol 45 2819-2828 [2007]
  • Antimicrobial susceptibility patterns for recent clinical isolates of anaerobic bacteria in South Korea
    Lee Y Antimicrob Agents Chemother 54 : 3993 ~ 3997 [2010]
  • Antimicrobial susceptibility patterns for recent clinical isolates of anaerobic bacteria in South Korea
    Lee Y Antimicrob Agents Chemother 54 3993-3997 [2010]
  • Antimicrobial resistance patterns of Bacteroides fragilis group organisms in Korea
    Lee K Yonsei Med J 39 : 578 ~ 586 [1998]
  • Antimicrobial resistance patterns of Bacteroides fragilis group organisms in Korea
    Lee K Yonsei Med J 39 578-586 [1998]
  • Antimicrobial Susceptibility of Clinical Isolates of Bacteroides fragilis Group Organisms Recovered from 2009 to 2012 in a Korean Hospital
  • Antimicrobial Susceptibility of Clinical Isolates of Bacteroides fragilis Group Organisms Recovered from 2009 to 2012 in a Korean Hospital
    임지숙 Annals of Laboratory Medicine 35 1 94-98 [2015]
  • Antianaerobic antimicrobials: spectrum and susceptibility testing
    Brook I Clin Microbiol Rev 26 : 526 ~ 546 [2013]
  • Antianaerobic antimicrobials: spectrum and susceptibility testing
    Brook I Clin Microbiol Rev 26 526-546 [2013]